INXN-2001

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameINXN-2001
Drug Alias NameControlled IL-12Ad-RTS-hIL-12 plus veledimexAdenoviral-vector-interleukin-12-gene-therapy-ZIOPHARM-OncologyAd-IL-12ZIN-ATI-001 +[10] 
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionGene transferenceInterleukin-12 stimulants
TargetsInterleukin-12
Therapy Area/IndicationsMetastatic breast cancerBrain NeoplasmsBreast Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlaunos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlaunos Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerBrain NeoplasmsBreast Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A